IQ-AI Limited (GB:IQAI) has released an update.
Braveheart Investment Group has acquired a significant 29.51% stake in IQ-AI Limited, an imaging software and healthcare diagnostics company, for £719,574.48. The shares were purchased from IQ-AI’s CEO Trevor Brown and a company owned by his children, aligning with Braveheart’s investment strategy. IQ-AI, which includes subsidiaries Imaging Biometrics and Stone Checker Software, recently reported a Phase 1 Clinical Trial progress, and the investment was deemed fair by Braveheart’s independent directors.
For further insights into GB:IQAI stock, check out TipRanks’ Stock Analysis page.
